Merck touts 20 new ‘blockbuster’ drugs in development with $50 billion potential
Merck's latest earnings call revealed a mix of growth and pain points for the pharmaceutical giant.
Merck Shares Hit After Guidance Falls Short, Gardasil Challenge
The drugmaker’s guidance was affected by a pause in shipments of its top-selling vaccine to China from February through at ...
Deutsche Bank Sticks to Their Buy Rating for Merck KGaA (0O14)
In a report released today, Falko Friedrichs from Deutsche Bank maintained a Buy rating on Merck KGaA (0O14 – Research Report), with a price ...
pharmaphorum9d
Merck gets FDA nod for new antibiotic, but says use with care
The FDA has approved a new triple-drug antibiotic from Merck & Co, but the company and ... including members of the Enterobacteriaceae family which includes several problem pathogens including ...
Business Wire16d
Merck KGaA, Darmstadt, Germany Announces Launch of Caregiver Leave Benefit, Strengthening Inclusive Family-Friendly Offerings
Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the introduction of a Caregiver ...
Yahoo Finance16d
Merck KGaA, Darmstadt, Germany Announces Launch of Caregiver Leave Benefit, Strengthening Inclusive Family-Friendly Offerings
2025--(BUSINESS WIRE)--Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the introduction of a Caregiver Leave Benefit as an additional family-friendly ...